... investigational agent for the treatment of chemotherapy-resistant malignant melanoma. Because most patients with metastatic melanoma fail to respond to available therapies, the discovery of a viable ...
... and scientific director at the Hoag Cancer Center and lead investigator for the study. "Patients with metastatic melanoma are at high risk for additional metastases and death."
During the study, 54 ...
... identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas ... leads to programmed cell death specifically in melanoma cells. Fisher said that mda-5 is a key ...
Scientists have identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas for drug development in melanoma -- a cancer that is highly resistant to current ...
... in Chicago.
This study builds on recent research about the first instance in which a woman’s metastatic melanoma was driven into remission by the targeted therapy drug, Gleevec, which was developed ...
... standard chemotherapy and radiation.
The patient in the journal report was one of nine patients with metastatic melanoma who were being treated in a recently completed clinical trial to test dose- ...
... IMP-3 protein. However, the protein was produced excessively in most melanomas, and overly expressed more often in metastatic melanomas.
IMP-3 was also over-expressed in rare cases of invasive thin ...
... cancer metastasis, this is the first study to examine the role of miRNA in metastatic melanoma.
"Melanoma becomes deadly after the cells leave the primary tumor through the blood and ...
... , resistant to therapy, and deadly. Now, scientists have identified the possible culprit -- a short strand of RNA called microRNA that is over-expressed in metastatic melanoma cell lines and tissues.
... in low doses.
"Selenium deficiency is common in cancer patients, including those diagnosed with metastatic melanoma," explained Robertson, whose findings appear in the March edition of Clinical ...
... treated with surgery alone.
"These early results are very exciting because metastatic melanoma is one of the most deadly cancers and one which is typically very unresponsive to therapy," said Georgia ...
... experiments we are doing right now will result in improved prognosis for patients with metastatic melanoma."
The scientists emphasized that although they engineered mice with very specific genetic ...
... . This discovery may offer therapeutic approaches for tackling metastatic melanoma, an aggressive form of skin cancer responsible for around 2,000 deaths in the UK each year.
... ,' Dr Izzie Stevens faces a grim diagnosis: stage IV metastatic melanoma. As the drama unfolds, viewers get a glimpse at why patients with the deadliest form of skin cancer - in ...
... genes and their switches that predict a patient's likelihood of responding to treatment for metastatic melanoma."
The results of this study are being validated in a larger sample of 80 patients. ...
